Japan Hospice Holdings Inc.

Japan Hospice Holdings Inc.

TTSE:7061
456.00
JPY
-3.00
(-0.65%)
4.44BMarket Cap
Nov 13Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
267.19
405.05
567.4
625.47
757.12
984.94
1,227.9
1,476.6
1,685.69
- -
Basic EPS, GAAP
-8.53
20.08
40.3
13.62
30.29
56.73
84.82
77.95
33.08
- -
Free Cash Flow per Basic Share
-9.53
20.73
33.35
-32.83
-181.82
42.52
-107.62
-276.39
-162.71
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
14.75
- -
Book Value per Share
28.78
48.86
137.57
158.93
192.11
250.14
334.02
416.98
436.46
431.76
Tangible Book Value per Share
-62.4
-35.41
62.79
92.65
134.36
188.99
279.33
369.83
389.96
390.24
Basic Weighted Avg Shares
7
7
7
8
8
8
8
8
8
8
Sales/Revenue/Turnover
1,895
3,015
4,194
4,917
6,019
7,894
9,872
12,115
14,169
- -
Operating Margin (%)
2.62
8.05
11.95
7.29
9.94
12.15
13
10.62
5.99
- -
Depreciation Expense
112
126
129
170
229
337
412
532
584
- -
Net Income, GAAP
-60
149
298
107
241
455
682
640
278
- -
Effective Tax Rate (%)
- -
24.74
23.11
48.05
42.32
38.96
33.69
36.55
49.86
- -
Profit Margin (%)
-3.19
4.96
7.1
2.18
4
5.76
6.91
5.28
1.96
- -
Working Capital
247
402
908
774
109
1,258
1,717
798
1,146
1,216
LT Debt
2,299
2,303
2,802
3,884
5,481
7,446
10,293
11,584
11,508
11,613
Total Equity
214
364
1,049
1,259
1,536
2,037
2,692
3,447
3,678
3,662
Return on Invested Capital (%)
- -
6.49
11.07
3.82
4.93
6.27
7.05
5.33
2.52
- -
Return on Capital (%)
- -
8.36
11.29
3.92
5.2
6.58
7.71
6.04
3.04
- -
Return on Common Equity (%)
- -
51.72
42.17
9.28
17.23
25.64
29
20.84
7.8
- -

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
ST Debt
930
- -
1,467
LT Borrowings
3,269
- -
3,023
LT Finance Leases
8,363
- -
8,589
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
11,992
6,084
4,436

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
Total Current Assets
3,590
- -
4,333
Cash, Cash Equivalents & STI
1,609
- -
1,929
Accounts Receivable, Net
1,838
- -
2,170
Inventories
- -
- -
- -
Total Current Liabilities
2,141
- -
3,116
Payables & Accruals
- -
- -
- -
ST Debt
930
- -
1,467
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
24.3%
6.71%
Free Cash Flow
- -
20.99%
-39.69%
Net Income, GAAP
- -
40.2%
-56.53%
Sales/Revenue/Turnover
- -
23.66%
16.95%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,725
2,956
- -
- -
12,115
2025
- -
- -
- -
- -
14,169
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
18.72
8.87
- -
- -
77.95
2025
- -
- -
- -
- -
33.08
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
14.75
2026
- -
- -
- -
- -
- -

Company Description

CEO
Tadashi Takahashi
Full Time Employees
1,108
Sector
Health services
Industry
Hospital/Nursing management
Address
Shin-Tokyo Building Tokyo TY Japan 100-0005
IPO Date
Mar 28, 2019
Business
Japan Hospice Holdings Inc. operates primarily in the healthcare sector in Japan, specializing in hospice housing and home care services for patients with terminal cancer and intractable diseases. The company provides comprehensive end-of-life care through its hospice houses, which are rental residences exclusively for patients requiring palliative care, and through a range of home care services including home visit nursing, small-scale multifunctional in-home nursing care known as Kantaki, day care services, and on-demand nursing care facilitated by certified care workers and helpers. Additionally, it offers housing management and nursing care services for elderly patients, as well as consulting and construction services related to healthcare facilities. Founded in 2017, the company is headquartered in Chiyoda-ku, Tokyo. In recent years, Japan Hospice Holdings has expanded its operations significantly, growing its revenue from 4.92 billion JPY in 2020 to 12.12 billion JPY in 2024. The company has pursued strategic business growth through acquisitions, including the recent acquisition of Alive Suginami-shoan, and has reinforced partnerships aimed at expanding home-visit prescription dispensing and enhancing integrated service delivery for hospice house residents. It is increasingly diversifying its hospice services to serve beyond cancer patients, aiming to broaden its user base and bolster facility expansions. These strategic moves underline Japan Hospice Holdings' commitment to expanding its footprint in the growing end-of-life care market in Japan, driven by the country’s aging demographic and rising demand for specialized hospice and home care services. The company targets Japan’s healthcare providers and elderly patients, focusing on palliative and home-based nursing care, utilizing a lean organizational structure to address nurse shortages and improve patient satisfaction. Its business segments include hospice housing, home nursing services, home care services, and healthcare-related construction and consulting. With a workforce of over 1,000 employees, Japan Hospice Holdings operates exclusively in Japan and continues to advance its mission of the study and popularization of home hospices, positioning itself as a leading provider in the palliative care and elderly nursing care space in the country.